WHO has launched a survey to identify the 50 top technologies people need worldwide to improve their lives. The survey, issued in the world’s 50 most spoken languages, will use the information gathered to build the WHO Priority Assistive Products List (APL), a tool that will set the standard for the most essential assistive products that must be available in a health system.
Health and trade have long been interconnected. By publishing Trade and Health: Towards a national strategy, WHO provides useful background information for policy-makers to formulate a coherent national response to trade and health-related issues. With free trade agreements being negotiated continuously, often without sufficient involvement of health experts, the core evidence presented in this book can enable health policy-makers to engage, where health and trade linkages occur, to protect health and thus strike a balance between public health and the further liberalization of global trade.
The Democratic Republic of Ethiopia, on 14 July 2015, launched an ambitious 10-year national strategy and plan of action to develop local pharmaceutical manufacturing capacity in order to increase access to locally manufactured, quality-assured medicines. The launch occurred on the side-lines of the 3rd Conference on Financing for Development.
On the occasion of the international conference on financing for development in Addis Ababa, the Prime Minister of Ethiopia with the World Health Organization (WHO) launched a 10-year strategic plan to develop its pharmaceutical manufacturing capacity in order to increase access to local quality-assured medicines. The launch took place on 14 July at 7 p.m. local time and was attended by numerous heads of international agencies.
Request for proposals
Implementing two strategies in harmony
Submission of an assessment report on the feasibility for establishing a pharmaceutical market data monitoring system in Ethiopia
WHO promotes, values and encourages health innovation
- Launch of Ethiopia’s National Strategy and Plan of Action for Pharmaceutical Manufacturing
- WHO publishes analysis of patent situation of new hepatitis treatments
- Follow-up of the report of the Consultative Expert Working Group on Research and Development: